Handelsbanken Fonder’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Handelsbanken Fonder’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-79,200	Closed	-$70K	–	1600
2022 Q4	$70K	Buy	79,200 +10,100	+15%	+$13.4K	﹤0.01%	1537
2022 Q3	$108K	Hold	69,100	–	–	﹤0.01%	1515
2022 Q2	$139K	Hold	69,100	–	–	﹤0.01%	1547
2022 Q1	$161K	Hold	69,100	–	–	﹤0.01%	1654
2021 Q4	$321K	Buy	69,100 +7,800	+13%	+$48.4K	﹤0.01%	1597
2021 Q3	$468K	Hold	61,300	–	–	﹤0.01%	1399
2021 Q2	$594K	Buy	61,300 +16,800	+38%	+$134K	﹤0.01%	1251
2021 Q1	$368K	Hold	44,500	–	–	﹤0.01%	1356
2020 Q4	$304K	Buy	+44,500	New	+$357K	﹤0.01%	1407

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return

Handelsbanken Fonder's SRNE Position: Q1 2023 in Review

Handelsbanken Fonder sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 79,200 shares — an estimated $70K sold.

Handelsbanken Fonder first reported a position in SRNE in Q4 2020 and held it in 9 quarters. The position peaked at $594K in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

Handelsbanken Fonder reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Handelsbanken Fonder sold 79,200 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $70K.
Handelsbanken Fonder first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 9 quarters.
Handelsbanken Fonder's Sorrento Therapeutics, Inc. position peaked at $594K in Q2 2021.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on Handelsbanken Fonder's 13F filing for Q1 2023, filed 28 Apr 2023.